Phio Pharmaceuticals Corp. (PHIO) Tops Q1 EPS by 9c

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q1 EPS of ($3.15), $0.09 better than the analyst estimate of ($3.24).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c